NEULAND LABORATORIES
Back to All Ratios
|
NEULAND LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 355.22 | 253.82 | 280.42 | 168.59 | 87.97 |
What is the latest Cash Earnings per Share (CEPS) ratio of NEULAND LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2026 | 355.22 |
| Mar2025 | 253.82 |
| Mar2024 | 280.42 |
| Mar2023 | 168.59 |
| Mar2022 | 87.97 |
How is Cash Earnings per Share (CEPS) of NEULAND LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2026 | 355.22 | 39.95 | |
| Mar2025 | 253.82 | -9.49 | |
| Mar2024 | 280.42 | 66.33 | |
| Mar2023 | 168.59 | 91.64 | |
| Mar2022 | 87.97 | - | |
Other Financial Ratios of NEULAND LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,245.9 Cr | -3% | 8.4% | 57.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,382.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,375.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,308.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹116,447.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,106.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -3% |
8.4% |
57.7% |
| SENSEX | 0.1% |
0.7% |
-6.6% |
You may also like the below Video Courses